Saturday, 28th September Asia Pacific Stroke Conference 2024

• Thrombectomy in Asia - current status and challenges - Son Tra Le Vu
• Thrombolysis in Acute Ischemic Stroke: More Thrombolytics Choices and Wider Time Windows - the Asian perspective - Yunyun Xiong
• Stroke unit in Asia - how to overcome the challenges - Hamidon Basri

• Reporting and analysis of process-of-care time measures for hyperacute stroke interventions - Dominic Italiano
• Take Charge After Stroke (TACAS): Examining implementation in routine care in a stroke support service - Felicity Bright
• Strategies to reduce delays in delivering Mechanical Thrombectomy for Acute Ischaemic Stroke – an Umbrella Review - Daniel Ameen
• Long-term effect of reorganization of in-hospital stroke code, a seven-year experience in a university hospital - Hiroyuki Kawano
• Impact of pay-for-performance incentives for stroke unit access on hospital costs and utilisation - Rohan S Grimley
• The evidence for Change Champions to increase evidence-into-practice: recommendations for stroke implementation trials - Elizabeth Lynch
• NSW rural stroke network patient care first - Donna Jay

• The outcomes in young adults with acute ischaemic stroke - Chushuang Chen
• Incomplete reperfusion associated with poor clinical outcomes despite successful revascularization after thrombectomy - Chushuang Chen
• Association between Bilateral Complete Fetal Type Posterior Cerebral Artery and Internal Carotid Artery Stenosis - Zhao Zhang
• What is the optimal rCBF threshold for ischemic core on CT perfusion? - Nakhoon Kim
• Demystifying DWI lesion volume changes in acute ischemic strokes - Nakhoon Kim
• Predicting post-stroke outcomes using CT perfusion-derived grey and white matter lesion volumes   - Oliver Sidgreaves

• Impact of Post-Stroke Aphasia on Prognosis after Stroke - Tomotaka TT Tanaka
• Cardiovascular disease and stroke prevention educational-behavioural programs for culturally and linguistically diverse communities: A systematic review and meta-analysis - Sabine Allida
• Bridging borders for the use of evidence-based protocols for Fever, Hyperglycaemia (Sugar) and Swallow (FeSS) and clinical practice: Findings from a qualitative study of factors influencing their sustained use - Kelly Coughlan
•   Burden of traditional medicine use for stroke rehabilitation in India: secondary analysis of ATTEND trial - Shiva Raj Mishra
• How do LGBTQI+ stroke survivors and their partners experience sex and sexuality after stroke? - william kokay
• Unmet needs, quality of life, mood and cognition amongst young adults accessing the Young Stroke Service - Sarah Amesz
• Behavioural activation-based psychoeducation for first-ever stroke survivors with depressive symptoms: preliminary results of a randomised controlled trial - Dan SHI

Session Schedule:

07:00-7:05 | Welcome address by Tsong-Hai Lee (Taipei)

07:05- 08:25 | (15 min/talk Χ 5 talks)

7:05AM | 1. Light and Shadow of Anti-Aβ Antibody Therapy.
Speaker: Toru Yamashita (Okayama)
Chair: Jose C. Navarro (Manila)

7:20AM | 2. The association between antihypertensive management and cognitive impairment. A review.
Speaker: Chi-Hung Liu (Taipei)
Chair: Jie Yang (Chengdu)

7:35AM | 3. Fluid and Neuroimaging biomarkers in Dementia-expanding horizons.
Speaker: Man Mohan Mehndiratta (New Delhi)
Chair: Tsong-Hai Lee (Taipei)

7:50AM | 4. Brain Age in Vascular Cognitive Impairment
Speaker: Lung Chan (Taipei)
Chair: Chaur-Jongh Hu (Taipei)

8:05AM | 5. Lower serum BDNF as a predictor of post-stroke cognitive impairment in acute ischemic stroke patients
Speaker: Amelia Nur Vidyanti (Jakarta)
Chair: Dong-Eog Kim (Seoul)

08:25 – 08:30 | Closing Remarks: Koji Abe (Tokyo)

08:30 – 08:35 | Brief leg stretching break

• VASCOG Asia: Light and Shadow of Anti-AB Antibody Therapy - Toru Yamashita
• The association between antihypertensive management and cognitive impairment. A review. - Chi-Hung Liu
• Fluid and Neuroimaging Biomarkers in Dementia-expanding Horizons - Man Mohan Mehndiratta
• Brain Age in Vascular Cognitive Impairment - Lung Chen
• Lower Serum BDNF as a predictor of post-stroke cognitive impairment in acute ischemic stroke patients - Amelia Nur Vidyanti

Session Schedule:

08:35 – 09:55 | (20 minute cognitive/vascular neurology/talk x 4 talks)

• Speaker: Nawaf Yassi, Amyloid angiopathy interaction with cognitive impairment
• Speaker: Toru Yamashita, Post-stroke cognitive impairment - Epidemiology and types 
• Speaker: Chaur Jong HU, Post-stroke cognitive impairment - Diagnosis and Treatment 
• Speaker: Amy Brodtmann, Novel and emerging treatments for Alzheimer's Disease - next frontiers

09:55 – 10:00 VasCog Group photo and then an additional joint photo with ANZSO colleagues

10:00 – 10:15 Vas-Cog Asia directors board meeting (please non-members leave the room)

• Amyloid angiopathy interaction with cognitive impairment - Nawaf Yassi
• Post-stroke cognitive impairment - Epidemiology and types - Toru Yamashita
• Post-stroke cognitive impairment - Diagnosis and Treatment - Chaur Jong HU
• Novel and emerging treatments for Alzheimer's Disease - next frontiers - Amy Brodtmann

• Minimal Invasive Surgery for ICH: technique and tips - Christopher Kellner
• Minimally Invasive cerebrovascular surgery: The Asia Pacific Perspective - Manabu Shirakawa
• Minimally invasive aneurysm clipping - Amal Abou-Hamden
• Endoscopic aneurysm treatment and molecular treatment of AVMs - Ivan Radovanovic

• A high-dose mobility booster program is feasible for people after stroke: a pilot randomised trial - Kate Scrivener
• Implementation of the Comprehensive High-Dose Aphasia Treatment (CHAT) program - Jade Dignam
• Boot camp accelerates arm recovery in chronic stroke - Brenton Hordacre
• The Queen Square Upper Limb Program - Nick Ward

8:30am - Opening - ASTN Co-Chairs

8:40am - Simeon Dale - QASC Australasia

8:45am - Fana Alemseged - POST-ETERNAL

8:50am - Bruce Campbell - EXTEND-IA DNase

8:55am - David Blacker - SEANCON

9:00am - Craig Anderson - I-CATCHER

9:05am - Felix Ng - EXTEND-AGNES

9:10am - Tim Kleinig - EVACUATE

9:15am - Tim Kleinig - LOTUS

9:20am - Kate Hayward - UPLIFT

9:25am - Kate Hayward - Fit4Me

9:30am - Geoffrey Cloud - CASPER

9:35am - Fiona Ellery - AVERT-DOSE

9:40am - Closing - ASTN Co-Chairs

• Twenty-Year Trend in prevalence and outcome of diabetes in acute ischemic stroke：Japan Stroke Data Bank - Kaori Miwa
• Validation of Linked Administrative Data to Determine Stroke Incidence in Aotearoa New Zealand - Anna Ranta
• Stroke in the Philippines, 2021-2023 - Maria Epifania Collantes
• Characterising stroke in Vietnamese Australians compared to a Caucasian population in South-Western Sydney - Deena Alysha
• Initial validation of a new measure of pre and post stroke outcome – the DBS24 - Helen M Badge
• Clinical characteristics of in-hospital ischaemic strokes - Elaine Cheung
• The association between prior hospital presentations and first-ever stroke differs by age and type of stroke but not sex   - SERAH KALPAKAVADI
• Changes in incidence of major pathological types of stroke in the Auckland Regional Community Stroke Studies: 2010-2022 - Rita V Krishnamurthi

• Transforming stroke prevention: From concept to global implementation. - Balakrishnan Nair
• Switch to rosuvastatin plus ezetimibe treatment from statin monotherapy for Target LDL-C goal achievement in patients with ischemic stroke, TIA or cerebral atherosclerosis. A multi-center, open-label, single arm trial - KEUN-SIK HONG
• Blood Pressure Variability and the Risk of Post-Stroke Cognitive Impairment Following Atrial Fibrillation related Acute Ischemic Stroke - Minwoo Lee
• Baseline Participant Characteristics in the PERsonalised Knowledge to reduce the risk of Stroke (PERKS-International) randomised controlled trial: Cross-Country Comparison - Shabnam Jalili-Moghaddam
• Longitudinal measurement of serum neurofilament light chain in patients with CADASIL - Jay Chol Choi
• Association between Admission Hematocrit Levels and Progressive Stroke in Patients with Single Small Subcortical Infarction: A Retrospective Cohort Study from the China National Stroke Registry III - Zefeng Tan
• Perivascular Space Progression In Patients With Cerebral Amyloid Angiopathy - Qi Li
• Precise Antiplatelet Therapy Guided by Platelet Aggregation Function in Ischemic Stroke - Yapeng Lin

• Intensive Ambulance-Delivered Blood-Pressure Reduction in Hyperacute Stroke - Jie Yang
• Outcomes associated to the time to treatment with intravenous reteplase for acute ischemic stroke: subgroup analysis of the RAISE randomized controlled clinical trial - Shuya Li
• Impact of body mass index on the efficacy and safety of tenecteplase versus alteplase in acute ischemic stroke patients - Shuhong Xu
• Edaravone Relieves Acute Ischemic Stroke Symptoms and Elevates Quality of Life (ERASE-STROKE): a phase III randomized double-blind placebo-controlled multicentre trial with TTYP-01 Tablet - xin-fu zhou

• Stroke Rehabilitation for Older Adults: time to Burn the Boats and try something new - Maria Crotty

Please meet at RAH Ground Floor (Level 3, Lift D) near the food court at 1:10 PM.

Complimentary with registration, RSVP compulsory

This workshop will be led by our invited keynote speaker and MIS pioneer Professor Chris Kellner and will focus on MIS techniques and troubleshooting, especially with the Integra Life Sciences AURORA Surgiscope and Evacuator. It is aimed especially at colleagues participating in (or interested in) the EVACUATE trial of MIS for ICH, but is open to all Colleagues who would like to learn more about this new frontier in stroke treatment.

Invited International Presenter: Prof Chris Kellner
Local Convenors: Amal Abou Hamden and Tim Kleinig